Mss51 protein inhibition serves as a novel target for type 2 diabetes: a molecular docking and simulation study.
J Biomol Struct Dyn
; : 1-8, 2023 Jun 20.
Article
in En
| MEDLINE
| ID: mdl-37338036
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
J Biomol Struct Dyn
Year:
2023
Document type:
Article
Affiliation country:
South Korea